Hereditary sclerosing poikiloderma: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
[[File:Autosomal_dominant_-_en.svg| | {{SI}} | ||
{{Infobox medical condition | |||
| | | name = Hereditary sclerosing poikiloderma | ||
| | | image = [[File:Autosomal_dominant_-_en.svg|200px]] | ||
| | | caption = [[Autosomal dominant]] pattern is the mode of inheritance for Hereditary sclerosing poikiloderma | ||
| synonyms = | |||
| symptoms = Poikiloderma, | | pronounce = | ||
| complications = | | specialty = [[Dermatology]] | ||
| onset = | | symptoms = [[Poikiloderma]], [[sclerosis]], skin atrophy, [[telangiectasia]], [[hyperpigmentation]] | ||
| duration = | | complications = Increased risk of [[skin cancer]] | ||
| types = | | onset = Childhood | ||
| causes = | | duration = Lifelong | ||
| risks = | | types = | ||
| diagnosis = | | causes = Genetic mutation | ||
| differential = | | risks = Family history | ||
| prevention = | | diagnosis = Clinical evaluation, [[genetic testing]] | ||
| treatment = | | differential = Other forms of [[poikiloderma]], [[scleroderma]] | ||
| medication = | | prevention = | ||
| prognosis = | | treatment = [[Sun protection]], [[topical corticosteroids]], [[laser therapy]] | ||
| frequency = | | medication = | ||
| prognosis = Variable, depends on severity | |||
| frequency = Rare | |||
}} | }} | ||
'''Hereditary sclerosing poikiloderma''', also known as '''Ferguson-Smith disease''', is a rare [[genetic disorder]] characterized by a combination of [[poikiloderma]], [[scleroderma]], and [[telangiectasia]]. | '''Hereditary sclerosing poikiloderma''', also known as '''Ferguson-Smith disease''', is a rare [[genetic disorder]] characterized by a combination of [[poikiloderma]], [[scleroderma]], and [[telangiectasia]]. | ||
== Signs and symptoms == | == Signs and symptoms == | ||
Individuals with hereditary sclerosing poikiloderma typically present with skin changes such as poikiloderma, which refers to a combination of skin atrophy, telangiectasia, and pigmentary changes. Scleroderma, characterized by hardening and tightening of the skin, may also be present. Telangiectasia, or small dilated blood vessels near the surface of the skin, is another common feature of this condition. | Individuals with hereditary sclerosing poikiloderma typically present with skin changes such as poikiloderma, which refers to a combination of skin atrophy, telangiectasia, and pigmentary changes. Scleroderma, characterized by hardening and tightening of the skin, may also be present. Telangiectasia, or small dilated blood vessels near the surface of the skin, is another common feature of this condition. | ||
== Causes == | == Causes == | ||
Hereditary sclerosing poikiloderma is caused by a [[genetic mutation]] that affects the skin's ability to regenerate and repair itself properly. | Hereditary sclerosing poikiloderma is caused by a [[genetic mutation]] that affects the skin's ability to regenerate and repair itself properly. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of hereditary sclerosing poikiloderma is typically based on clinical evaluation of the characteristic skin changes and may be confirmed through genetic testing. | Diagnosis of hereditary sclerosing poikiloderma is typically based on clinical evaluation of the characteristic skin changes and may be confirmed through genetic testing. | ||
== Treatment == | == Treatment == | ||
There is currently no specific treatment for hereditary sclerosing poikiloderma. Management typically involves symptomatic relief and supportive care to address the skin manifestations and associated symptoms. | There is currently no specific treatment for hereditary sclerosing poikiloderma. Management typically involves symptomatic relief and supportive care to address the skin manifestations and associated symptoms. | ||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with hereditary sclerosing poikiloderma varies depending on the severity of symptoms and complications. Regular monitoring and management by a dermatologist or geneticist may help improve quality of life for affected individuals. | The prognosis for individuals with hereditary sclerosing poikiloderma varies depending on the severity of symptoms and complications. Regular monitoring and management by a dermatologist or geneticist may help improve quality of life for affected individuals. | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Dermatologic terminology]] | [[Category:Dermatologic terminology]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 04:12, 7 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Hereditary sclerosing poikiloderma | |
|---|---|
| |
| Synonyms | |
| Pronounce | |
| Specialty | Dermatology |
| Symptoms | Poikiloderma, sclerosis, skin atrophy, telangiectasia, hyperpigmentation |
| Complications | Increased risk of skin cancer |
| Onset | Childhood |
| Duration | Lifelong |
| Types | |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Clinical evaluation, genetic testing |
| Differential diagnosis | Other forms of poikiloderma, scleroderma |
| Prevention | |
| Treatment | Sun protection, topical corticosteroids, laser therapy |
| Medication | |
| Prognosis | Variable, depends on severity |
| Frequency | Rare |
| Deaths | N/A |
Hereditary sclerosing poikiloderma, also known as Ferguson-Smith disease, is a rare genetic disorder characterized by a combination of poikiloderma, scleroderma, and telangiectasia.
Signs and symptoms[edit]
Individuals with hereditary sclerosing poikiloderma typically present with skin changes such as poikiloderma, which refers to a combination of skin atrophy, telangiectasia, and pigmentary changes. Scleroderma, characterized by hardening and tightening of the skin, may also be present. Telangiectasia, or small dilated blood vessels near the surface of the skin, is another common feature of this condition.
Causes[edit]
Hereditary sclerosing poikiloderma is caused by a genetic mutation that affects the skin's ability to regenerate and repair itself properly.
Diagnosis[edit]
Diagnosis of hereditary sclerosing poikiloderma is typically based on clinical evaluation of the characteristic skin changes and may be confirmed through genetic testing.
Treatment[edit]
There is currently no specific treatment for hereditary sclerosing poikiloderma. Management typically involves symptomatic relief and supportive care to address the skin manifestations and associated symptoms.
Prognosis[edit]
The prognosis for individuals with hereditary sclerosing poikiloderma varies depending on the severity of symptoms and complications. Regular monitoring and management by a dermatologist or geneticist may help improve quality of life for affected individuals.
